Explore the cutting-edge field of gene therapy for sickle cell disease in this comprehensive lecture. Delve into various gene therapy solutions, underlying technologies, and notable pre-clinical and clinical achievements. Gain insights into the potential risks and benefits associated with gene therapy for hemoglobin disorders. Learn about antiviral vectors, CRISPR systems, DNA break mechanisms, and genotoxicity concerns. Examine clinical trials, including BB305, BC11A, and G206, and their results, safety profiles, and durability. Analyze hemolysis markers and understand the current challenges and future prospects of gene therapy in treating sickle cell disease.
Gene Therapy Solutions for Sickle Cell Disease - Lecture 15
The Royal College of Pathologists via YouTube
Overview
Syllabus
Introduction
Outline
Transplant
Gene therapy
Risks
Strategies
Antiviral vectors
CRISPR system
DNA break
HD vs NHEJ
Offtarget genotoxicity
Ontarget genotoxicity
Base transversion
Summary
BB305
Clinical trials
Results
Crisis
Safety
Durability
Conclusion
BC11A
G206
BC118
Excessile
Hemolysis markers
Taught by
The Royal College of Pathologists
Related Courses
-
Comprehensive Molecular Diagnostics and Advanced Gene Expression Analysis
-
CRISPR - Cas9 Gene Therapy and CAR T-Cell Therapy - Promising?
-
CRISPR 2.0 - The Next Generation of Gene Editing Therapy
-
Redefining Precision in Precision Medicine - Learning from Gene Therapy Trials
-
Molecular Techniques Lecture - Molecular Biology Techniques and Cell Biology Techniques
4.0
